In breast cancer, RANK/RANKL signaling is required for cancerous mammary epithelial cell proliferation, and RANK-deficient mice manifest a markedly delayed hormone- and oncogen-driven breast carcinogenesis [37]. This evidence concerns the gene TNFRSF11A and breast carcinoma.